Redox control of the cell cycle: a radical encounter.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 15890015)

Published in Antioxid Redox Signal on May 13, 2005

Authors

Emily C Rothstein, Pamela A Lucchesi

Articles by these authors

Left ventricular eccentric remodeling and matrix loss are mediated by bradykinin and precede cardiomyocyte elongation in rats with volume overload. J Am Coll Cardiol (2007) 2.21

Early heart failure in the SMNDelta7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery. Hum Mol Genet (2010) 1.89

Capacitative calcium entry contributes to nuclear factor of activated T-cells nuclear translocation and hypertrophy in cardiomyocytes. J Biol Chem (2002) 1.89

Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes. Antioxid Redox Signal (2003) 1.33

Cardiac mast cell- and chymase-mediated matrix metalloproteinase activity and left ventricular remodeling in mitral regurgitation in the dog. J Mol Cell Cardiol (2003) 1.32

Extracellular matrix remodeling during the progression of volume overload-induced heart failure. J Mol Cell Cardiol (2009) 1.32

Cardiovascular remodeling in response to long-term exposure to fine particulate matter air pollution. Circ Heart Fail (2012) 1.20

The visceral pericardium: macromolecular structure and contribution to passive mechanical properties of the left ventricle. Am J Physiol Heart Circ Physiol (2007) 1.12

Beta1-adrenergic receptor blockade attenuates angiotensin II-mediated catecholamine release into the cardiac interstitium in mitral regurgitation. Circulation (2003) 1.11

Role of advanced glycation end products with oxidative stress in resistance artery dysfunction in type 2 diabetic mice. Arterioscler Thromb Vasc Biol (2008) 1.10

Endothelial nitric oxide signaling regulates Notch1 in aortic valve disease. J Mol Cell Cardiol (2013) 1.09

Coronary arterioles in type 2 diabetic (db/db) mice undergo a distinct pattern of remodeling associated with decreased vessel stiffness. Basic Res Cardiol (2011) 1.08

Identification of a receptor-independent activator of G protein signaling (AGS8) in ischemic heart and its interaction with Gbetagamma. Proc Natl Acad Sci U S A (2006) 1.07

In vivo and in vitro cardiac responses to beta-adrenergic stimulation in volume-overload heart failure. J Mol Cell Cardiol (2012) 1.07

Myocardial dysfunction in an animal model of cancer cachexia. Life Sci (2010) 1.04

Congenital heart disease-causing Gata4 mutation displays functional deficits in vivo. PLoS Genet (2012) 1.03

Temporal pattern of left ventricular structural and functional remodeling following reversal of volume overload heart failure. J Appl Physiol (1985) (2011) 1.03

Limited utility of acetoxymethyl (AM)-based intracellular delivery systems, in vivo: interference by extracellular esterases. J Microsc (2007) 1.03

Dynamic micro- and macrovascular remodeling in coronary circulation of obese Ossabaw pigs with metabolic syndrome. J Appl Physiol (1985) (2012) 1.02

Systemic maternal inflammation and neonatal hyperoxia induces remodeling and left ventricular dysfunction in mice. PLoS One (2011) 1.02

H(2)O(2)-induced Ca(2+) overload in NRVM involves ERK1/2 MAP kinases: role for an NHE-1-dependent pathway. Am J Physiol Heart Circ Physiol (2002) 0.97

PYK2 signaling is required for PDGF-dependent vascular smooth muscle cell proliferation. Am J Physiol Cell Physiol (2011) 0.96

Cardiac interstitial bradykinin and mast cells modulate pattern of LV remodeling in volume overload in rats. Am J Physiol Heart Circ Physiol (2003) 0.95

Role of SHP-1, Kv.1.2, and cGMP in nitric oxide-induced ERK1/2 MAP kinase dephosphorylation in rat vascular smooth muscle cells. Cardiovasc Res (2005) 0.94

Mesenteric resistance arteries in type 2 diabetic db/db mice undergo outward remodeling. PLoS One (2011) 0.94

Ecstasy produces left ventricular dysfunction and oxidative stress in rats. Cardiovasc Res (2008) 0.94

The angiotensin converting enzyme 2/Ang-(1-7) axis in the heart: a role for MAS communication? Circ Res (2008) 0.93

Detection of left ventricular hypertrophy in rats administered a peroxisome proliferator-activated receptor alpha/gamma dual agonist using natriuretic peptides and imaging. Toxicol Sci (2009) 0.89

Oxidative stress contributes to methamphetamine-induced left ventricular dysfunction. Cardiovasc Res (2010) 0.88

Altered PYK2 phosphorylation by ANG II in hypertensive vascular smooth muscle. Am J Physiol Heart Circ Physiol (2002) 0.87

Metabolites of MDMA induce oxidative stress and contractile dysfunction in adult rat left ventricular myocytes. Cardiovasc Toxicol (2009) 0.87

A role for PYK2 in ANG II-dependent regulation of the PHAS-1-eIF4E complex by multiple signaling cascades in vascular smooth muscle. Am J Physiol Cell Physiol (2003) 0.86

Signal transduction of physiological concentrations of vasopressin in A7r5 vascular smooth muscle cells. A role for PYK2 and tyrosine phosphorylation of K+ channels in the stimulation of Ca2+ spiking. J Biol Chem (2001) 0.83

Mice lacking the gene encoding for MMP-9 and resistance artery reactivity. Biochem Biophys Res Commun (2006) 0.83

NAD(P)H oxidases and TGF-beta-induced cardiac fibroblast differentiation: Nox-4 gets Smad. Circ Res (2005) 0.82

Collagen XIV is important for growth and structural integrity of the myocardium. J Mol Cell Cardiol (2012) 0.82

Hydrogen peroxide acts as relaxing factor in human vascular smooth muscle cells independent of map-kinase and nitric oxide. Front Biosci (2006) 0.81

Nitric oxide-induced collagen IV expression and angiogenesis: FAK or fiction? Focus on "Collagen IV contributes to nitric oxide-induced angiogenesis of lung endothelial cells". Am J Physiol Cell Physiol (2011) 0.81

Enhanced Steatosis and Fibrosis in Liver of Adult Offspring Exposed to Maternal High-Fat Diet. Gene Expr (2016) 0.80

Differential coronary resistance microvessel remodeling between type 1 and type 2 diabetic mice: impact of exercise training. Vascul Pharmacol (2012) 0.80

Activation of gadolinium-sensitive ion channels in cardiomyocytes in early adaptive stages of volume overload-induced heart failure. Cardiovasc Res (2006) 0.79

Mitogen activated protein kinase activation and oxidant signaling in astrocytoma cells. J Neurooncol (2002) 0.79

PPAR-gamma agonists decrease hyperhomcysteinemia and cardiac dysfunction: new hope for ailing diabetic hearts? Am J Physiol Heart Circ Physiol (2006) 0.79

Right ventricular remodeling in restrictive ventricular septal defect. J Mol Cell Cardiol (2010) 0.77

Rapamycin plays a new role as differentiator of vascular smooth muscle phenotype. focus on "The mTOR/p70 S6K1 pathway regulates vascular smooth muscle differentiation". Am J Physiol Cell Physiol (2004) 0.77

Use of angiotensin-converting enzyme inhibitors in patients with diabetes and coronary artery disease. Curr Probl Cardiol (2002) 0.77

Myofilament dysfunction as an emerging mechanism of volume overload heart failure. Pflugers Arch (2014) 0.77

ANG II and cardiac myocyte contractility: p38 is not stressed out! Am J Physiol Heart Circ Physiol (2006) 0.77

Is resveratrol the magic bullet for pulmonary hypertension? Hypertension (2009) 0.77

Matrix metalloproteinase in left ventricular remodeling and heart failure. Curr Cardiol Rep (2003) 0.76

Peroxisome proliferator ameliorates endocardial endothelial and muscarinic dysfunction in spontaneously hypertensive rats. Antioxid Redox Signal (2004) 0.76

Stress adaptation and the resilience of youth: fact or fiction? Physiology (Bethesda) (2014) 0.75

Growth hormone-releasing peptides and the heart: secretagogues or cardioprotectors? Cardiovasc Res (2004) 0.75

Curcuminoids: Spicing up sympathovagal tone. Nutrition (2009) 0.75

Vascular dysfunction in diabetes. Vascul Pharmacol (2012) 0.75